4.8 Article

Molybdenum Trioxide Nanocubes Aligned on a Graphene Oxide Substrate for the Detection of Norovirus by Surface-Enhanced Raman Scattering

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 12, Issue 39, Pages 43522-43534

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.0c14729

Keywords

molybdenum nanocubes; single-layer graphene oxide; dual SERS nanotag/substrate; SERS-based immunoassay; norovirus; immunomagnetic separation

Funding

  1. Japan Society for the Promotion of Science (JSPS) [19F19348]
  2. Grants-in-Aid for Scientific Research [19F19348] Funding Source: KAKEN

Ask authors/readers for more resources

A novel biosensing system based on graphene-mediated surface-enhanced Raman scattering (G-SERS) using plasmonic/magnetic molybdenum trioxide nanocubes (mag-MoO3 NCs) has been designed to detect norovirus (NoV) via a dual SERS nanotag/substrate platform. A novel magnetic derivative of MoO3 NCs served as the SERS nanotag and the immunomagnetic separation material of the biosensor. Single-layer graphene oxide (SLGO) was adopted as the 2D SERS substrate/capture platform and acted as the signal reporter, with the ability to accommodate an additional Raman molecule as a coreporter. The developed SERS-based immunoassay achieved a signal amplification of up to similar to 10(9)-fold resulting from the combined electromagnetic and chemical mechanisms of the dual SERS nanotag/substrate system. The developed biosensor was employed for the detection of NoV in human fecal samples collected from infected patients by capturing the virus with the aid of NoV-specific antibody-functionalized magnetic MoO3 NCs. This approach enabled rapid signal amplification for NoV detection with this biosensing technology. The biosensor was tested and optimized using NoV-like particles within a broad linear range from 10 fg/mL to 100 ng/mL and a limit of detection (LOD) of similar to 5.2 fg/mL. The practical applicability of the developed biosensor to detect clinical NoV subtypes in human fecal samples was demonstrated by effective detection with an LOD of similar to 60 RNA copies/mL, which is similar to 10(3)-fold lower than that of a commercial enzyme-linked immunosorbent assay kit for NoV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available